Roche Diagnostics announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyzer series, an integrated system designed for ...

Basel, 17 March 2021– Roche announced today the launch of cobas pure integrated solutions in countries accepting the CE mark. 3 This new compact analyser combines three technologies1 on a single ...

[2] Roche cobas e 801 Immunochemistry Assay Method Sheets [3] Reduction is a comparison to cobas c 501 module, part of cobas® 6000 analyser series [4] Reduction is a comparison to cobas e 601 module, ...

With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needsThis will allow a greater number ...

INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, the next ...

The cobas® pulse system is Roche’s newest generation of connected professional blood glucose management solution, building on its legacy with Accu-Chek® Inform II. Designed with advanced safety and ...

Basel, 11 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today introduced cobas® infinity edge, a secure and encrypted cloud-based platform for the integration and management of point of care ...

cobas pure integrated solutions brings together three diagnostic technologies 1 on a single platform to optimise space and resources in small to medium laboratory settings With a footprint of just ...

Roche Diagnostics announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution ...

cobas® pure integrated solutions brings together three diagnostic technologies1 on a single platform to optimise space and resources in small to medium laboratory settingsWith a footprint of just ...